| Literature DB >> 35983157 |
Yutao Zhang1, Quan Sheng1, Xidong Fu2, Haifeng Shi3, Zhuqing Jiao1,2.
Abstract
The clinical scores are applied to determine the stage of cognitive function in patients with end-stage renal disease (ESRD). However, accurate clinical scores are hard to come by. This paper proposed an integrated prediction framework with GPLWLSV to predict clinical scores of cognitive functions in ESRD patients. GPLWLSV incorporated three parts, graph theoretic algorithm (GTA) and principal component analysis (PCA), whale optimization algorithm with Levy flight (LWOA), and least squares support vector regression machine (LSSVRM). GTA was adopted to extract features from the brain functional networks in ESRD patients, while PCA was used to select features. LSSVRM was built to explore the relationship between the selected features and the clinical scores of ESRD patients. Whale optimization algorithm (WOA) was introduced to select better parameters of the kernel function in LSSVRM; it aims to improve the exploration competence of LSSVRM. Levy flight was used to optimize the ability to jump out of local optima in WOA and improve the convergence of coefficient vectors in WOA, which lead to an increase in the generalization ability and convergence speed of WOA. The results validated that the prediction accuracy of GPLWLSV was higher than that of several comparable frameworks, such as GPSV, GPLSV, and GPWLSV. In particular, the average of root mean square error (RMSE), mean absolute error (MAE), and mean absolute percentage error (MAPE) between the predicted scores and the actual scores of ESRD patients was 2.40, 2.06, and 9.83%, respectively. The proposed framework not only can predict the clinical scores more accurately but also can capture imaging markers associated with decline of cognitive function. It helps to understand the potential relationship between structural changes in the brain and cognitive function of ESRD patients.Entities:
Mesh:
Year: 2022 PMID: 35983157 PMCID: PMC9381242 DOI: 10.1155/2022/8124053
Source DB: PubMed Journal: Comput Intell Neurosci
Figure 1A flowchart of prediction framework.
Demographic information of subjects.
| Gender (male/female) | Age (years, | Education years (years, | Clinical scores (points, | |
|---|---|---|---|---|
| ESRD patients ( | 27/23 | 49.12 ± 8.23 | 11.13 ± 2.05 | 21.47 ± 2.75 |
| Normal controls ( | 22/18 | 47.26 ± 7.01 | 11.24 ± 2.13 | 27.38 ± 1.35 |
|
| 0.009 | 1.133 | 0.387 | −13.412 |
|
| >0.05 | 0.260 | 0.778 | 0.000 |
Comparison of AUC of global topological parameters between two groups (mean ± SD).
| Parameter | ESRD patients ( | Normal controls ( |
|
|
|---|---|---|---|---|
|
| 0.646 ± 0.071 | 0.669 ± 0.056 | −1.714 | 0.004 |
|
| 0.326 ± 0.123 | 0.329 ± 0.024 | 0.710 | 0.480 |
|
| 0.589 ± 0.065 | 0.607 ± 0.065 | −1.384 | 0.008 |
| Cp | 0.175 ± 0.014 | 0.176 ± 0.016 | −0.296 | 0.768 |
| Lp | 0.543 ± 0.027 | 0.553 ± 0.069 | −0.966 | 0.337 |
| Eglobal | 0.171 ± 0.006 | 0.170 ± 0.011 | −0.477 | 0.635 |
| Elocal | 0.230 ± 0.007 | 0.241 ± 0.006 | −0.253 | 0.001 |
Weight of AUC of global topological parameters of ESRD patients in feature set.
| Parameter |
|
|
| Cp (%) | Lp (%) | Eglobal (%) | Elocal (%) |
|---|---|---|---|---|---|---|---|
|
| 0.03 | 0.07 | 0.17 | 0.28 | 3.25 | 30.89 | 65.31 |
Prediction accuracies of comparable frameworks.
| Prediction framework | The test group | RMSE | MAE | MAPE |
|---|---|---|---|---|
| GPSV | 1 | 3.5064 | 2.3835 | 0.1364 |
| GPSV | 2 | 3.482 | 3.0951 | 0.1454 |
| GPSV | 3 | 3.2648 | 2.8499 | 0.1267 |
| GPSV | 4 | 3.6154 | 3.1792 | 0.1542 |
| GPSV | 5 | 2.5508 | 2.2965 | 0.1109 |
| GPSV | 6 | 2.2724 | 1.7919 | 0.079 |
| GPSV | 7 | 4.115 | 3.6825 | 0.1788 |
| GPSV | 8 | 2.8204 | 2.659 | 0.1277 |
| GPSV | 9 | 5.7247 | 4.0523 | 0.1999 |
| GPSV | 10 | 3.0707 | 2.7852 | 0.1334 |
| Average | 3.4423 | 2.8775 | 0.1392 | |
| GPLSV | 1 | 5.2634 | 4.197 | 0.2149 |
| GPLSV | 2 | 4.6628 | 3.1899 | 0.1305 |
| GPLSV | 3 | 3.4819 | 2.8121 | 0.1491 |
| GPLSV | 4 | 3.1611 | 2.7837 | 0.1385 |
| GPLSV | 5 | 2.1046 | 1.8884 | 0.0898 |
| GPLSV | 6 | 2.162 | 2.1246 | 0.0994 |
| GPLSV | 7 | 3.3545 | 3.0199 | 0.1524 |
| GPLSV | 8 | 3.9891 | 3.725 | 0.18 |
| GPLSV | 9 | 2.2805 | 1.7733 | 0.0812 |
| GPLSV | 10 | 2.8879 | 2.4838 | 0.1214 |
| Average | 3.3348 | 2.7998 | 0.1357 | |
| GPWLSV | 1 | 4.2408 | 3.4782 | 0.1695 |
| GPWLSV | 2 | 3.3293 | 2.8178 | 0.124 |
| GPWLSV | 3 | 3.0657 | 2.4178 | 0.1188 |
| GPWLSV | 4 | 3.3027 | 2.9839 | 0.1466 |
| GPWLSV | 5 | 1.3125 | 1.1388 | 0.0529 |
| GPWLSV | 6 | 1.9272 | 1.4114 | 0.0618 |
| GPWLSV | 7 | 2.9412 | 2.7196 | 0.1311 |
| GPWLSV | 8 | 2.7899 | 2.6865 | 0.1284 |
| GPWLSV | 9 | 2.6758 | 2.3282 | 0.1092 |
| GPWLSV | 10 | 3.0313 | 2.8014 | 0.1335 |
| Average | 2.8616 | 2.4784 | 0.1176 | |
| GPLWLSV | 1 | 3.9132 | 3.1026 | 0.1561 |
| GPLWLSV | 2 | 3.2506 | 2.8334 | 0.1258 |
| GPLWLSV | 3 | 2.7307 | 2.4334 | 0.1075 |
| GPLWLSV | 4 | 2.9976 | 2.3738 | 0.1216 |
| GPLWLSV | 5 | 1.2192 | 1.1111 | 0.053 |
| GPLWLSV | 6 | 0.718 | 0.6497 | 0.0313 |
| GPLWLSV | 7 | 2.5167 | 2.1156 | 0.1036 |
| GPLWLSV | 8 | 2.0709 | 1.9636 | 0.0914 |
| GPLWLSV | 9 | 2.1757 | 1.9467 | 0.0916 |
| GPLWLSV | 10 | 2.4163 | 2.0302 | 0.1007 |
| Average | 2.4009 | 2.056 | 0.0983 |
Figure 2Average of prediction accuracies of various frameworks. (a) The RMSE and MAE of various frameworks. (b) The MAPE of various frameworks.
Figure 3Actual scores and predicted scores of various frameworks. (a) GPSV, (b) GPLSV, (c) GPWLSV, and (d) GPLWLSV.
Figure 4Relationship between node efficiency and clinical scores.
Figure 5Brain regions with statistically significant differences in node efficiency between the two groups. (a) Left lateral view, (b) right lateral view, (c) left lateral view, (d) right lateral view, and (e) dorsal view of the whole brain.